Mikael Wiberg Selected Research

Acetylcarnitine (Alcar)

1/2012	Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats.
11/2011	The nerve injury and the dying neurons: diagnosis and prevention.
7/2010	Acetyl-l-carnitine increases nerve regeneration and target organ reinnervation - a morphological study.
1/2007	Delayed acetyl-L-carnitine administration and its effect on sensory neuronal rescue after peripheral nerve injury.
12/2003	Primary sensory neuronal rescue with systemic acetyl-L-carnitine following peripheral axotomy. A dose-response analysis.
12/2002	Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment.
7/2002	Systemic acetyl-L-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikael Wiberg Research Topics

Disease

13	Peripheral Nerve Injuries 01/2018 - 02/2002
10	Wounds and Injuries (Trauma) 01/2017 - 07/2002
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 08/2002
2	Cerebral Palsy (Spastic Diplegia) 11/2015 - 04/2015
2	Muscular Atrophy (Muscle Atrophy) 05/2013 - 04/2006
1	Inflammation (Inflammations) 04/2016
1	Atrophy 05/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Cicatrix (Scar) 01/2013
1	Weight Loss (Weight Reduction) 07/2010

Drug/Important Bio-Agent (IBA)

7	Acetylcarnitine (Alcar)IBA 01/2012 - 07/2002
3	Neuroprotective AgentsIBA 01/2012 - 12/2002
2	Nerve Growth Factors (Neurotrophins)IBA 01/2018 - 08/2002
2	Cysteine (L-Cysteine)FDA Link 01/2012 - 11/2011
2	Peptides (Polypeptides)IBA 10/2010 - 12/2003
2	HydrogelsIBA 10/2010 - 08/2002
1	poly-4-dioxan-2-oneIBA 01/2018
1	caprolactoneIBA 01/2018
1	trimethylene carbonateIBA 01/2018
1	ChitosanIBA 04/2016
1	incobotulinumtoxinA FDA Link 11/2015
1	Type A Botulinum Toxins (Botox)FDA Link 11/2015
1	Proteoglycans (Proteoglycan)IBA 01/2013
1	FibrinIBA 05/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011
1	Calcitonin Gene-Related PeptideIBA 08/2011
1	Serotonin (5 Hydroxytryptamine)IBA 08/2011
1	salicylhydroxamic acid (SHAM)IBA 07/2010
1	PlacebosIBA 07/2010
1	Green Fluorescent ProteinsIBA 09/2004
1	Saline SolutionIBA 12/2003
1	Fibronectins (Fibronectin)IBA 08/2002
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2002
1	poly-beta-hydroxybutyrateIBA 08/2002
1	AlginatesIBA 08/2002

Therapy/Procedure

5	Axotomy 07/2011 - 07/2002
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 06/2012
3	Transplantation 01/2018 - 02/2002
3	Denervation 04/2015 - 01/2003
2	Therapeutics 01/2021 - 01/2007
2	Injections 11/2015 - 05/2013
1	Cell Transplantation 01/2021
1	Sutures (Suture) 11/2009
1	Absorbable Implants 08/2002